Long-time collaborators Konica Medical Imaging and Minolta have merged to become Konica Minolta Medical Imaging, USA. The new company is expected to capitalize on broad assets previously held in the two separate firms, particularly in research and
Long-time collaborators Konica Medical Imaging and Minolta have merged to become Konica Minolta Medical Imaging, USA. The new company is expected to capitalize on broad assets previously held in the two separate firms, particularly in research and development, as well as manufacturing, marketing, and service capabilities, according to company president Terry Hasegawa. The merger will not affect existing relationships with sales and distribution partners. Headquarters for the newly combined company will be in Wayne, NJ. The company will continue to produce CR, laser imagers, and networking tools, as well as laser and specialty film and film processing equipment.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.